Muutke küpsiste eelistusi

E-raamat: Novartis Foundation Symposium 281 - Decoding the Genomic Control of Immune Reactions [Wiley Online]

Edited by , Edited by
  • Formaat: 232 pages
  • Sari: Novartis Foundation Symposia
  • Ilmumisaeg: 09-Mar-2007
  • Kirjastus: John Wiley & Sons Inc
  • ISBN-10: 470062126
  • ISBN-13: 9780470062128
  • Wiley Online
  • Hind: 238,95 €*
  • * hind, mis tagab piiramatu üheaegsete kasutajate arvuga ligipääsu piiramatuks ajaks
  • Formaat: 232 pages
  • Sari: Novartis Foundation Symposia
  • Ilmumisaeg: 09-Mar-2007
  • Kirjastus: John Wiley & Sons Inc
  • ISBN-10: 470062126
  • ISBN-13: 9780470062128
Judging from this collection of reports on recent research, great progress is being made toward using the genome sequences of humans, mice and other vertebrates to solve key problems in immunological disease and chronic infections. However, researchers are finding a barrier in the identification of key sequences and circuits controlling the relevant immune reactions. Drawn from material presented at the Novartis Foundation Symposium entitled "Decoding the Genomic Control of Immune Reactions" held in Canberra in March 2006, this collection covers transcriptional regulatory networks in macrophages, molecular pathways and their role in human disease, specifying the patterns of immune cell migration, human monogenic disorders and their relationship with specific infections, the genetic control of susceptibility to a strain of tuberculosis, disorders resulting from defective LAT signalosomes, smallpox and mousepox, strategies for phenotype detection and subsequent mapping and cloning, genetic control of host-pathogen interactions, systems genetics, and regulation of the immune system. Annotation ©2007 Book News, Inc., Portland, OR (booknews.com)

This book explores existing and potential strategies for using the genome sequences of human, mouse, other vertebrates and human pathogens to solve key problems in the treatment of immunological diseases and chronic infections.  The assembled genome sequences now provide important opportunities for solving these problems, but a major bottleneck is the identification of key sequences and circuits controlling the relevant immune reactions. This will require innovative, interdisciplinary and collaborative strategies of a scale and complexity we are only now beginning to comprehend.

Specific problems addressed include the following:

  • What kinds of information are we lacking to understand how the genome sequence specifies the differentiation and response of immune system cells, and system behaviour such as immunological memory and tolerance?
  • Which genome sequences and cellular circuits cause or prevent pathological immune responses to foreign pathogens, allergens or self-tissues?
  • Which host and pathogen genome sequences and cellular circuits explain the failure of sterilizing immune responses to sophisticated human pathogens such as the agents of tuberculosis, malaria, metazoan parasites and chronic viruses?

Containing contributions from a range of leading experts in the field, this book provides an important new perspective for clinical immunologists and basic researchers alike.

Introduction (Chris Goodnow).
Transcriptional regulatory networks in macrophages. (David A. Hume, Christine A. Wells and Timothy Ravasi).
Discussion.
The RIKEN mouse transcriptome: lessons learned and implications for the regulation of immune reactions (Christian Schönbach).
Discussion.
Molecular pathways for lymphangiogenesis and their role in human disease (Steven A. Stacker, Rae H. Farnsworth, Tara Karnezis, Ramin Shayan,.
Darrin P. Smith, Karri Paavonen, Natalia Davydova, Carol Caesar,.
Rachael Inder, Megan E. Baldwin, Bradley K. McColl, Sally Roufail,.
Richard A. Williams, Richard A. Hughes, Kari Alitalo and.
Marc G. Achen).
Discussion.
General discussion I.
Specifying the patterns of immune cell migration (Jason G. Cyster).
Discussion.
Human monogenic disorders that confer predisposition to specifi c infections (Capucine Picard, Laurent Abel and Jean-Laurent Casanova).
Discussion.
The genetic control of susceptibility to Mycobacterium tuberculosis (W. J. Britton, S. L. Fernando, B. M. Saunders, R. Sluyter and J. S. Wiley).
Discussion.
Th2 lymphoproliferative disorders resulting from defective LAT signalosomes (Bernard Malissen, Ying Wang, Michael Mingueneau and Marie Malissen).
Discussion.
Genetic analysis of systemic autoimmunity (Carola G. Vinuesa and Matthew C. Cook).
Discussion.
Genetic resistance to smallpox: lessons from mousepox (Gunasegaran Karupiah, Vijay Panchanathan, Isaac G. Sakala and Geeta Chaudhri).
Discussion.
The AcB/BcA recombinant congenic strains of mice: strategies for phenotype dissection, mapping and cloning of quantitative trait genes (Anny Fortin, Eduardo Diez, Janet E. Henderson, Jeffrey S. Mogil, Philippe Gros and Emil Skamene).
Discussion.
Genetic control of host–pathogen interactions in mice (Gundula Min-Oo, Mary M. Stevenson, Anny Fortin and Philippe Gros).
Discussion.
Mycobacterium tuberculosis and its ability to resist immunity (Douglas Young and Anne O’Garra).
Discussion.
Systems genetics: the next generation in genetics research? (Grant Morahan and Robert W. Williams).
Discussion.
Regulation of the immune system in metazoan parasite infections (Rick Maizels).
Discussion.
Closing remarks (Chris Goodnow).
Contributor Index.
Subject Index. 9780470027554


The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.